QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

AXSM

QT70Axsome Therapeutics, Inc.
NASDAQ·Healthcare·Biotechnology·USA
Latest market price
250.50
-1.66-0.66%
OverviewShort InterestFilings
AXSMQT70Axsome Therapeutics, Inc.·NASDAQ
OverviewShort InterestFilings
250.50-0.66%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E-EPS (ttm)
-3.73
Insider Own3.96%
Shs Outstand51.46M
Perf Week-1.29%
Market Cap12.98BForward P/E45.35EPS next Y5.52Insider Trans0.74%Shs Float-Perf Month10.51%
Enterprise Value12.89BPEG-EPS next Q-0.83Inst Own-Short Float-Perf Quarter57.67%
Income-189450981.00P/S18.32EPS this Y47.39%Inst Trans-Short Ratio-Perf Half Y70.56%
Sales708.24MP/B236.51EPS next Y381.48%ROA-26.39%Short Interest-Perf YTD37.16%
Book/sh1.07P/C-EPS next 5Y-ROE-260.01%52W High260.18 -3.72%Perf Year146.56%
Cash/sh5.93P/FCF-EPS past 3/5Y-ROIC-50.29%52W Low96.09 160.69%Perf 3Y-
Dividend Est.-EV/EBITDA-74.64Sales past 3/5Y133.68% -Gross Margin92.60%Volatility2.14% 2.58%Perf 5Y-
Dividend TTM-EV/Sales18.20EPS Y/Y TTM36.06%Oper. Margin-24.80%ATR (14)8.53Perf 10Y-
Dividend Ex-Date-Quick Ratio1.32Sales Y/Y TTM83.42%Profit Margin-26.59%RSI (14)67.37Recom2.09
Dividend Gr. 3/5Y-Current Ratio1.39EPS Q/Q-57.50%SMA204.39%Beta0.60Target Price262.38
Payout0.00%Debt/Eq4.03Sales Q/Q57.85%SMA5014.90%Rel Volume1.00Prev Close252.16
Employees712LT Debt/Eq1.91EarningsAug 03SMA20049.00%Avg Volume766.81KPrice250.50
IPO DateNov 19, 2015Option/ShortYes / YesEPS/Sales Surpr.-48.24% -1.05%Net Debt/EBITDA0.49Volume770,641Change-0.66%
Analyst Ratings
DateActionAnalystRatingTarget
Jun-11-26ReiteratedJefferiesBuy$275 → $380
May-05-26ReiteratedDeutsche Bank$281 → $280
May-05-26ReiteratedRobert W. Baird$241 → $246
May-05-26ReiteratedH.C. WainwrightBuy$270 → $290
May-05-26ReiteratedMorgan StanleyEqual Weight$217 → $242
May-05-26ReiteratedNeedhamBuy$225 → $267
May-05-26ReiteratedRBC CapitalOutperform$222 → $302
May-04-26ReiteratedOppenheimer$250 → $280
May-04-26ReiteratedPiper SandlerOverweight$223 → $258
May-04-26ReiteratedCantor FitzgeraldOverweight$234 → $272
Latest News
Jun-17-26
Jun-17-2609:53AM
TD Cowen Maintains Buy on Axsome Therapeutics, Raises Price Target to $300Benzinga
Jun-15-26
Jun-15-2607:10AM
Axsome to Present New Sleep Disorder Data at SLEEP 2026, To Highlight AXS-12 and Solriamfetol Data for Narcolepsy and OSABenzinga
Jun-12-26
Jun-12-2609:31AM
Rapport ‘fully prepared’ to launch seizure drug solo, CEO saysYahoo
Jun-11-26
Jun-11-2602:01PM
Agitation in Alzheimer's Disease Market to Register Immense Growth at a CAGR of 14.9% During the Forecast Period (2026-2036) | DelveInsightYahoo
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
FY 2024
12/31/2024
FY 2023
12/31/2023
FY 2022
12/31/2022
FY 2021
12/31/2021
FY 2020
12/31/2020
FY 2019
12/31/2019
FY 2018
12/31/2018
Total Revenue708638386
Upgrade your experience to unlock full historical data
Cost of Goods Sold Incl. D&A524733
Gross Profit656591352
Selling, General and Administrative Excl. Other634571411
Research and Development192183187
Other Operating Expense5635
Operating Income-175-169-281
Interest Expense577
Unusual Expense
———
Non-Operating Income (Expense)680
Net Income Before Taxes-189-184-287
Income Taxes-1-10
Consolidated Net Income-189-183-287
Net Income From Continuing Operations-189-183-287
Net Income-189-183-287
EPS (Recurring)-3.73-3.68-5.99
EPS (Basic, Before Extraordinaries)-3.73-3.68-5.99
EPS (Diluted)-3.73-3.68-5.99
EBITDA-173-168-273
Other After Tax Adjustments
———
Stock Option Compensation Expense
———
Price To Earnings Ratio
———
Price To Sales Ratio18.0414.31—
Gross Margin92.6692.6391.19
Operating Margin-24.72-26.49-72.80
Net Margin-26.69-28.68-74.35
Shares Outstanding515048
Market Capitalization12,7769,132—
Operating Lease Expense
———
Insider Trading Volume
$269.28$238.52$207.76$177.00$146.24● Close Price0.00M6.88M13.76M20.64M27.52MUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
Insider Trading
InsiderRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Form 4
JEFFS ROGERDirectorJun 11 '26Sale249.1228671,24858,367Jun 11 12:00 AM
JEFFS ROGERDirectorJun 10 '26Sale246.1828670,40758,653Jun 11 12:00 AM
Coleman MarkDirectorJun 10 '26Sale249.00643160,10730,389Jun 10 12:00 AM
Mahony SusanDirectorJun 10 '26Sale246.1830073,854829Jun 10 12:00 AM
Mahony SusanDirectorJun 09 '26Sale237.2130071,1631,129Jun 10 12:00 AM
Saad Mark EDirectorJun 08 '26Option Exercise0.002,858011,431Jun 10 12:00 AM
Mahony SusanDirectorJun 08 '26Option Exercise0.002,85801,429Jun 10 12:00 AM
JEFFS ROGERDirectorJun 08 '26Option Exercise0.002,858058,939Jun 10 12:00 AM
Coleman MarkDirectorJun 08 '26Option Exercise0.002,858031,032Jun 10 12:00 AM
Pizzie NickChief Financial OfficerJun 09 '26Option Exercise3.5066,000231,00075,867Jun 09 12:00 AM
Pizzie NickChief Financial OfficerJun 09 '26Sale240.0933,0007,922,97042,867Jun 09 12:00 AM
TABUTEAU HERRIOTChief Executive OfficerJun 09 '26Option Exercise122.9899,34012,216,83499,330Jun 09 12:00 AM
TABUTEAU HERRIOTChief Executive OfficerJun 09 '26Sale241.0149,67011,970,9677,229Jun 09 12:00 AM
Coleman MarkDirectorJun 02 '26Sale223.395,5371,236,91029,603Jun 02 12:00 AM
Coleman MarkDirectorJun 01 '26Sale230.306,0001,381,80035,140Jun 02 12:00 AM
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR